Transcept Pharmaceuticals Inc (NASDAQ:TSPT)
| 3.10 Data as of May 24 |  +0.02 / +0.65%Today’s Change | 2.87 Today|||52-Week Range 7.45 | -30.34% Year-to-Date |
Latest TSPT News | Press Releases
No recent news for Transcept Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.08 |
| Today’s open | 3.10 |
| Day’s range | 3.00 - 3.11 |
| Volume | 162,905 |
| Average volume (3 months) | 142,466 |
| Market cap | $58.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -141.38% |
| Earnings growth (this year) | -76.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -44.50% |
| P/E ratio | NM |
| Price/Sales | 7.91 |
| Price/Book | 0.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYCCCyclacel Pharmaceuti... | +0.07 | +2.20% |
| --Hubei Minkang Pharma... | 0.00 | 0.00% |
| MNOVMediciNova Inc | -0.03 | -0.95% |
| CBRXColumbia Laboratorie... | -0.00 | -0.16% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $9.6M |
| Annual profit (last year) | -$12.0M |
| Net profit margin | -125.21% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Glenn A. Oclassen, Sr. |
Chief Operating Officer & Executive Vice President Thomas P. Soloway, MBA |
Corporate headquarters Point Richmond, California |
Forecasts
